119 related articles for article (PubMed ID: 23178825)
1. miR-106a overexpression and pRB downregulation in sporadic colorectal cancer.
Catela Ivkovic T; Aralica G; Cacev T; Loncar B; Kapitanovic S
Exp Mol Pathol; 2013 Feb; 94(1):148-54. PubMed ID: 23178825
[TBL] [Abstract][Full Text] [Related]
2. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
3. miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide.
Jiang Y; Wu Y; Greenlee AR; Wu J; Han Z; Li X; Zhao Y
Toxicol Sci; 2011 Jan; 119(1):50-60. PubMed ID: 20889678
[TBL] [Abstract][Full Text] [Related]
4. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
[TBL] [Abstract][Full Text] [Related]
5. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.
Simpson DJ; Hibberts NA; McNicol AM; Clayton RN; Farrell WE
Cancer Res; 2000 Mar; 60(5):1211-6. PubMed ID: 10728677
[TBL] [Abstract][Full Text] [Related]
6. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
[TBL] [Abstract][Full Text] [Related]
7. miR-21 functionally interacts with the 3'UTR of chemokine CCL20 and down-regulates CCL20 expression in miR-21 transfected colorectal cancer cells.
Vicinus B; Rubie C; Faust SK; Frick VO; Ghadjar P; Wagner M; Graeber S; Schilling MK
Cancer Lett; 2012 Mar; 316(1):105-12. PubMed ID: 22099878
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma.
Choy KW; Pang CP; Yu CB; Wong HL; Ng JS; Fan DS; Lo KW; Chai JT; Wang J; Fu W; Lam DS
Hum Mutat; 2002 Nov; 20(5):408. PubMed ID: 12402348
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C
Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894
[TBL] [Abstract][Full Text] [Related]
10. miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2).
Qin Y; Chen X; Liu Z; Tian X; Huo Z
Med Sci Monit; 2018 Jul; 24():4944-4951. PubMed ID: 30011263
[TBL] [Abstract][Full Text] [Related]
11. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
[TBL] [Abstract][Full Text] [Related]
12. MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
Deng Y; Huang Z; Xu Y; Jin J; Zhuo W; Zhang C; Zhang X; Shen M; Yan X; Wang L; Wang X; Kang Y; Si J; Zhou T
Cancer Lett; 2014 Jan; 342(1):27-35. PubMed ID: 23981575
[TBL] [Abstract][Full Text] [Related]
13. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.
Reid JF; Sokolova V; Zoni E; Lampis A; Pizzamiglio S; Bertan C; Zanutto S; Perrone F; Camerini T; Gallino G; Verderio P; Leo E; Pilotti S; Gariboldi M; Pierotti MA
Mol Cancer Res; 2012 Apr; 10(4):504-15. PubMed ID: 22343615
[TBL] [Abstract][Full Text] [Related]
14. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
[TBL] [Abstract][Full Text] [Related]
15. Promoter CpG methylation of caveolin-1 in sporadic colorectal cancer.
Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chang JG
Anticancer Res; 2004; 24(3a):1645-50. PubMed ID: 15274335
[TBL] [Abstract][Full Text] [Related]
16. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
[TBL] [Abstract][Full Text] [Related]
17. miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response.
Scarola M; Schoeftner S; Schneider C; Benetti R
Cancer Res; 2010 Sep; 70(17):6925-33. PubMed ID: 20713524
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of RB1 transcript is significantly correlated with 13q14 allelic imbalance in colorectal carcinomas.
Lai PS; Cheah PY; Kadam P; Chua CL; Lie DK; Li HH; Eu KW; Seow-Choen F; Lee AS
Int J Cancer; 2006 Sep; 119(5):1061-6. PubMed ID: 16570290
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.
Feng L; Xie Y; Zhang H; Wu Y
Biochem Biophys Res Commun; 2011 Mar; 406(4):534-8. PubMed ID: 21352815
[TBL] [Abstract][Full Text] [Related]
20. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]